Dr Avinash Pilar
Telephone:
Email:
Location:
- University College Hospital
GMC/GDC number:
7837884
Professional background
Dr Avinash Pilar completed his oncology training at Tata Memorial Centre, Mumbai, India in 2018. He then proceeded to obtain fellowship experience in Oncology at various renowned cancer centres in the world, Princess Margaret Cancer Centre, Toronto, Canada (2018-2020), Christie NHS FT (2020-21) and University College London Hospitals (2021-22).
Dr Avinash Pilar now specialises in the treatment of soft tissue and bone sarcomas using radiotherapy. He also has a strong interest in clinical research and teaching.
Research interests
Head and neck sarcoma
Soft tissue and bone sarcoma
Languages spoken
Hindi, Kannada, Konkani
Publications
Patel SA, Ma TM, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Krauss. DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, DeWeese TL, Tilki D, Ciezki JP, Karnes RJ, Nickols NG, Rettig MB, Feng FY, Berlin A, Tward. JD, Davis BJ, Reiter RE, Boutros PC, Romero T, Horwitz EM, Tendulkar RD, Steinberg ML, Spratt DE, Xiang M, Kishan AU. External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):645-653. doi: 10.1016/j.ijrobp.2022.09.075. Epub 2022. Sep 28. PMID: 36179990.
Kishan AU, Steigler A, Denham JW, Zapatero A, Guerrero A, Joseph D, Maldonado, X, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt, T, DeWeese TL, Ross AE, Ciezki JP, Tilki D, Karnes RJ, Tosoian JJ, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Jiang T, Ma TM, Xiang M, Philipson R, Chang A, Kupelian PA, Rettig MB, Feng FY, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Boutros PC, Horwitz EM, Tendulkar RD, Spratt DE, Romero T. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3. Cohorts. JAMA Oncol. 2022 Mar 1;8(3):e216871. doi: 10.1001/jamaoncol.2021.6871. Epub 2022 Mar 17. PMID: 35050303; PMCID: PMC8778608.
Mahantshetty U, Gurram L, Bushra S, Ghadi Y, Aravindakshan D, Paul J, Hande, V, Pilar A, Chopra S, Ghosh J, Shylasree TS, Popat P, Sable N, Maheswari A, Gupta S. Single Application Multifractionated Image Guided Adaptive High-Dose-Rate Brachytherapy for Cervical Cancer: Dosimetric and Clinical Outcomes. Int J, Radiat Oncol Biol Phys. 2021 Nov 1;111(3):826-834. doi: 10.1016/j.ijrobp.2021.06.014. Epub 2021 Jun 17. PMID: 34146636.
Pilar A, Yu E, Su J, O'Sullivan B, Bartlett E, Waldron JN, Ringash J, Spreafico A, Hansen AR, de Almeida J, Bayley A, Bratman SV, Cho J, Giuliani M, Hope A, Hosni A, Kim J, Tong L, Xu W, Huang SH. Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN. classification for HPV-negative oropharyngeal carcinoma. Oral Oncol. 2021 Mar;114:105167. doi: 10.1016/j.oraloncology.2020.105167. Epub 2021 Jan 25. PMID:33508706.
Pilar A, Gravel SB, Croke J, Soliman H, Chung P, Wong RKS. Coronavirus Disease 2019's (COVID-19's) Silver Lining-Through the Eyes of Radiation Oncology Fellows. Adv Radiat Oncol. 2021 Jan-eb;6(1):100527. doi: 10.1016/j.adro.2020.07.004. Epub 2020 Jul 23. PMID: 32838070; PMCID: PMC7377812.
Ghosh-Laskar S, Pilar A, Johnny C, Prabhash K, Joshi A, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Swain M, Noronha V, Patil VM, Pai P, Nair D, Chaukar DA, Thiagarajan S, Pantvaidya G, Deshmukh A, Chaturvedi P, Nair S, D'Cruz A. Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era. World J Otorhinolaryngol Head Neck Surg. 2020 Apr 3;6(1):25-33. doi:10.1016/j.wjorl.2020.02.003. PMID: 32426700; PMCID: PMC7221210.
Agarwal JP, Pilar A, Mummudi N, Gupta M, Laskar SG, Pathak RS, Tibdewal AR, Kinhikar R, Ghadi Y, Tandon S, Purandare N, Prabhash K, Patil V. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer: Tata Memorial Hospital perspective and practice recommendations. Indian J Cancer. 2020 Jan-Mar;57(1):18-24. doi: 10.4103/ijc.IJC_216_18. PMID: 31929233.
Ghosh-Laskar S, Pilar A, Prabhash K, Joshi A, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Swain M, Noronha V, Patil VM, Pai P, Nair D, Chaukar DA, Thiagarajan S, Pantvaidya G, Deshmukh A, Chaturvedi P, Nair S, D'Cruz A. Taxane-based Induction Chemotherapy Plus Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma: Prospective Results from a Non-endemic Cohort. Clin Oncol (R Coll
Radiol). 2019 Dec;31(12):850-857. doi: 10.1016/j.clon.2019.06.011. Epub 2019 Jul 8. PMID: 31296457.
Agarwal JP, Kane S, Ghosh-Laskar S, Pilar A, Manik V, Oza N, Wagle P, Gupta T, Budrukkar A, Murthy V, Swain M. Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eye. Laryngoscope. 2019 May;129(5):1130-1136. doi: 10.1002/lary.27508. Epub 2018 Nov 13. PMID: 30421434.
Laskar S, Pilar A, Khanna N, Puri A, Gulia A, Qureshi S, Chinnaswamy G, Vora T, Ramadwar M. Interstitial brachytherapy for pediatric soft tissue sarcoma: Evolving practice over three decades and long-term outcomes. Pediatr Blood Cancer. 2018 Sep;65(9):e27112. doi: 10.1002/pbc.27112. Epub 2018 May 10. PMID: 29745023.
Laskar S, Pilar A, Khanna N, Ghadi Y. Interstitial brachytherapy for orbital soft tissue sarcoma: an innovative technique. J Contemp Brachytherapy. 2017. Oct;9(5):466-471. doi: 10.5114/jcb.2017.70957. Epub 2017 Oct 19. PMID: 29204167; PMCID: PMC5705832.
Pilar A, Gupta M, Ghosh Laskar S, Laskar S. Intraoperative radiotherapy: review of techniques and results. Ecancermedicalscience. 2017 Jun 29;11:750. doi: 10.3332/ecancer.2017.750. PMID: 28717396; PMCID: PMC5493441.